Targeting of TAK1 in inflammatory disorders and cancer

Hiroaki Sakurai

doi:10.1016/j.tips.2012.06.007

journal article Oct 01, 2012

Targeting of TAK1 in inflammatory disorders and cancer

Hiroaki Sakurai

Trends in Pharmacological Sciences Vol. 33 No. 10 pp. 522-530 · Elsevier BV

View at Publisher Save 10.1016/j.tips.2012.06.007

Topics

No keywords indexed for this article. Browse by subject →

References

93

[1]

Yamaguchi "Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction" Science (1995) 10.1126/science.270.5244.2008

[2]

Shirakabe "TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase" J. Biol. Chem. (1997) 10.1074/jbc.272.13.8141

[3]

Sakurai "TGF-β-activated kinase 1 stimulates NF-κB activation by an NF-κB-inducing kinase-independent mechanism" Biochem. Biophys. Res. Commun. (1998) 10.1006/bbrc.1998.8124

[4]

Ninomiya-Tsuji "The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway" Nature (1999) 10.1038/18465

[5]

Sakurai "Functional interactions of transforming growth factor β-activated kinase 1 with IκB kinases to stimulate NF-κB activation" J. Biol. Chem. (1999) 10.1074/jbc.274.15.10641

[6]

Sorrentino "The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner" Nat. Cell Biol. (2008) 10.1038/ncb1780

[7]

Yamashita "TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β" Mol. Cell (2008) 10.1016/j.molcel.2008.09.002

[8]

Landström "The TAK1–TRAF6 signalling pathway" Int. J. Biochem. Cell Biol. (2010) 10.1016/j.biocel.2009.12.023

[9]

Yamazaki "Two mechanistically and temporally distinct NF-κB activation pathways in IL-1 signaling" Sci. Signal. (2009) 10.1126/scisignal.2000387

[10]

Shibuya "TAB1: an activator of the TAK1 MAPKKK in TGF-β signal transduction" Science (1996) 10.1126/science.272.5265.1179

[11]

Takaesu "TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway" Mol. Cell (2000) 10.1016/s1097-2765(00)80244-0

[12]

Ishitani "Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling" EMBO J. (2003) 10.1093/emboj/cdg605

[13]

Sato "Essential function for the kinase TAK1 in innate and adaptive immune responses" Nat. Immunol. (2005) 10.1038/ni1255

[14]

Shim "TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo" Genes Dev. (2005) 10.1101/gad.1360605

[15]

Sekimoto "Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis" Mech. Dev. (2002) 10.1016/s0925-4773(02)00391-x

[16]

Sanjo "TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling" Mol. Cell. Biol. (2003) 10.1128/mcb.23.4.1231-1238.2003

[17]

Singhirunnusorn "Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-β-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2" J. Biol. Chem. (2005) 10.1074/jbc.m407537200

[18]

Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NFκB and AP-1 Activation as Well as IL-6 Gene Expression

Yang Yu, Ningling Ge, Min Xie et al.

Journal of Biological Chemistry 2008 10.1074/jbc.m802825200

[19]

Pathak "O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release" EMBO J. (2000) 10.1038/emboj.2012.8

[20]

Chen "Ubiquitination in signaling to and activation of IKK" Immunol. Rev. (2012) 10.1111/j.1600-065x.2012.01108.x

[21]

Tokunaga "LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses" Microbes Infect. (2012) 10.1016/j.micinf.2012.01.011

[22]

Kulathu "Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain" Nat. Struct. Mol. Biol. (2009) 10.1038/nsmb.1731

[23]

Komander "Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains" EMBO Rep. (2009) 10.1038/embor.2009.55

[24]

Sato "Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by NZF domains of TAB2 and TAB3" EMBO J. (2009) 10.1038/emboj.2009.345

[25]

Fan "Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor α- and interleukin-1β-induced IKK/NF-κB and JNK/AP-1 activation" J. Biol. Chem. (2010) 10.1074/jbc.m109.076976

[26]

Xia "Direct activation of protein kinases by unanchored polyubiquitin chains" Nature (2009) 10.1038/nature08247

[27]

Kajino "Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway" J. Biol. Chem. (2006) 10.1074/jbc.m608155200

[28]

Cheung "Feedback control of the protein kinase TAK1 by SAPK2a/p38α" EMBO J. (2003) 10.1093/emboj/cdg552

[29]

Ahmed "The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation" Nat. Immunol. (2011) 10.1038/ni.2157

[30]

Fan "Lys(48)-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation" Cell. Signal. (2012) 10.1016/j.cellsig.2012.02.017

[31]

Miyamoto "Nuclear initiated NF-κB signaling: NEMO and ATM take center stage" Cell Res. (2011) 10.1038/cr.2010.179

[32]

Hinz "A cytoplasmic ATM–TRAF6–cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation" Mol. Cell (2010) 10.1016/j.molcel.2010.09.008

[33]

Wu "ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress" Mol. Cell (2010) 10.1016/j.molcel.2010.09.010

[34]

TGFβ signalling: a complex web in cancer progression

Hiroaki Ikushima, Kohei Miyazono

Nature Reviews Cancer 2010 10.1038/nrc2853

[35]

Mao "TAK1 lysine 158 is required for TGF-β-induced TRAF6-mediated Smad-independent IKK/NF-κB and JNK/AP-1 activation" Cell. Signal. (2011) 10.1016/j.cellsig.2010.09.006

[36]

Kim "Transforming growth factor-β (TGF-β1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-β receptor kinase activity in mesangial cells" J. Biol. Chem. (2009) 10.1074/jbc.m109.007146

[37]

Várady "TTRAP is a novel component of the non-canonical TRAF6–TAK1 TGF-β signaling pathway" PLoS ONE (2011) 10.1371/journal.pone.0025548

[38]

Karin "NF-κB: linking inflammation and immunity to cancer development and progression" Nat. Rev. Immunol. (2005) 10.1038/nri1703

[39]

Wagner "Fos/AP-1 proteins in bone and the immune system" Immunol. Rev. (2005) 10.1111/j.0105-2896.2005.00332.x

[40]

Gaestel "Protein kinases as small molecule inhibitor targets in inflammation" Curr. Med. Chem. (2007) 10.2174/092986707781696636

[41]

Thome "Antigen receptor signaling to NF-κB via CARMA1, BCL10, and MALT1" Cold Spring Harb. Perspect. Biol. (2010) 10.1101/cshperspect.a003004

[42]

Sun "The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes" Mol. Cell (2004) 10.1016/s1097-2765(04)00236-9

[43]

Shinohara "PKCβ regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1" J. Exp. Med. (2005) 10.1084/jem.20051591

[44]

Schuman "A critical role of TAK1 in B-cell receptor-mediated nuclear factor κB activation" Blood (2009) 10.1182/blood-2008-08-176057

[45]

Shinohara "IκB kinase β-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells" J. Exp. Med. (2007) 10.1084/jem.20070379

[46]

He "The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88" Nat. Immunol. (2010) 10.1038/ni.1914

[47]

Wan "The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function" Nat. Immunol. (2006) 10.1038/ni1355

[48]

Liu "Essential role of TAK1 in thymocyte development and activation" Proc. Natl. Acad. Sci. U.S.A. (2006) 10.1073/pnas.0603089103

[49]

Sato "TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells" Int. Immunol. (2006) 10.1093/intimm/dxl082

[50]

Zhao "The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells" J. Biol. Chem. (2011) 10.1074/jbc.m111.292961

Showing 50 of 93 references

Cited By

329

Astragaloside IV ameliorates atherosclerosis by targeting TAK1 to suppress endothelial cell proinflammatory activation

Shuang Hua, Han Zhang · 2025

International Immunopharmacology

Post-Translational Modification of p62: Roles and Regulations in Autophagy

Shuai Xiao, Yeping Yu · 2025

Cells

The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation

Chinnaswamy Tiruppathi, Dheeraj Soni · 2014

Nature Immunology

Mitogen-activated protein kinases in innate immunity

J. Simon C. Arthur, Steven C. Ley · 2013

Nature Reviews Immunology

Metrics

329

Citations

93

References

Details

Published: Oct 01, 2012
Vol/Issue: 33(10)
Pages: 522-530
License: View

Authors

H

Hiroaki Sakurai

Cite This Article

Hiroaki Sakurai (2012). Targeting of TAK1 in inflammatory disorders and cancer. Trends in Pharmacological Sciences, 33(10), 522-530. https://doi.org/10.1016/j.tips.2012.06.007

Targeting of TAK1 in inflammatory disorders and cancer

You May Also Like